drugset / Trial / NCT01402219
Nephrotoxicity of Iopamidol Versus Iodixanol in High-Risk Patients
Phase 4
Terminated
204 enrolled
Guangdong Provincial People's Hospital
First Affiliated Hospital, Sun Yat-Sen University · collabGuangzhou General Hospital of Guangzhou Military Command · collabNanfang Hospital, Southern Medical University · collabSun Yat-Sen Memorial Hospital of Sun Yat-Sen University · collab
RandomizedParallel-groupTriple-blindDiagnostic
Summary
The purpose of this study is to compare the incidence of contrast-induced nephropathy (CIN) following the administration of iopamidol-370 (Iopamiro-370) and iodixanol-320 (Visipaque 320) in patients with chronic kidney disease undergoing coronary angiography.
Timeline
- Start
- 2008-11
- Primary completion
- 2013-02
- Completion
- 2013-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Iodixanol | Diagnostic / imaging agent | — | — |
| Comparator | Iopamidol | Diagnostic / imaging agent | 76 % | — |